ARYD |
ARYA Sciences Acquisition Corp IV |
Jul 31, 2024 |
3 |
$0 |
4 |
Jul 31, 2024 |
Chief Financial Officer, Director, 10%+ Owner |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 14, 2024 |
1 |
$0 |
4 |
Jun 17, 2024 |
Director |
LYRA |
Lyra Therapeutics, Inc. |
Jun 13, 2024 |
1 |
$0 |
4 |
Jun 14, 2024 |
Director |
PCSC |
Perceptive Capital Solutions Corp |
Jun 13, 2024 |
1 |
$2.86M |
4 |
Jun 13, 2024 |
Chief Business Officer, Director, 10%+ Owner |
PCSC |
Perceptive Capital Solutions Corp |
Jun 11, 2024 |
0 |
$0 |
3 |
Jun 11, 2024 |
Chief Business Officer, Director |
LYRA |
Lyra Therapeutics, Inc. |
Jun 30, 2023 |
1 |
$0 |
4 |
Jul 5, 2023 |
Director |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 15, 2023 |
1 |
$0 |
4 |
Jun 20, 2023 |
Director |
LYRA |
Lyra Therapeutics, Inc. |
Jun 16, 2022 |
1 |
$0 |
4 |
Jun 21, 2022 |
Director |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 15, 2022 |
1 |
$0 |
4 |
Jun 17, 2022 |
Director |
ARYE |
ARYA Sciences Acquisition Corp V |
Jul 15, 2021 |
1 |
$4.99M |
4 |
Jul 15, 2021 |
Chief Financial Officer, Director, 10%+ Owner |
ARYE |
ARYA Sciences Acquisition Corp V |
Jul 12, 2021 |
0 |
$0 |
3 |
Jul 12, 2021 |
Chief Financial Officer, Director, 10%+ Owner |
NAUT |
Nautilus Biotechnology, Inc. |
Jun 9, 2021 |
5 |
$0 |
4 |
Jun 11, 2021 |
Director |
LYRA |
Lyra Therapeutics, Inc. |
May 26, 2021 |
1 |
$0 |
4 |
May 28, 2021 |
Director |